Splicing regulation as a potential genetic modifier

被引:176
作者
Nissim-Rafinia, M [1 ]
Kerem, B [1 ]
机构
[1] Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel
关键词
D O I
10.1016/S0168-9525(01)02619-1
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Inherited diseases are associated with profound phenotypic variability, which is affected strongly by genetic modifiers. The splicing machinery could be one such modifying system,through a mechanism involving splicing motifs and their interaction with a complex repertoire of splicing factors. Mutations in splicing motifs and changes in levels of splicing factors can result in different splicing patterns. Changes in the level of normal transcripts or in the relative pattern of different mRNA isoforms affect disease expression, leading to phenotypic variability. Here, we discuss the splicing machinery in terms of its significance in disease severity and its potential role as a genetic modifier.
引用
收藏
页码:123 / 127
页数:5
相关论文
共 61 条
  • [1] Donor splice-site mutations in WT1 are responsible for Frasier syndrome
    Barbaux, S
    Niaudet, P
    Gubler, MC
    Grunfeld, JP
    Jaubert, F
    Kuttenn, F
    Fekete, CN
    SouleyreauTherville, N
    Thibaud, E
    Fellous, M
    McElreavey, K
    [J]. NATURE GENETICS, 1997, 17 (04) : 467 - 470
  • [2] Barka T, 1998, J CELL BIOCHEM, V69, P201, DOI 10.1002/(SICI)1097-4644(19980501)69:2<201::AID-JCB10>3.0.CO
  • [3] 2-H
  • [4] Baudry D, 2000, CLIN CANCER RES, V6, P3957
  • [5] Bièche I, 1999, CANCER RES, V59, P2546
  • [6] REGULATION OF ALTERNATIVE SPLICING IN-VIVO BY OVEREXPRESSION OF ANTAGONISTIC SPLICING FACTORS
    CACERES, JF
    STAMM, S
    HELFMAN, DM
    KRAINER, AR
    [J]. SCIENCE, 1994, 265 (5179) : 1706 - 1709
  • [7] Cardozo AK, 2000, PEDIATR RES, V48, P748
  • [8] Treatment of spinal muscular atrophy by sodium butyrate
    Chang, JG
    Hsieh-Li, HM
    Jong, YJ
    Wang, NM
    Tsai, CH
    Li, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (17) : 9808 - 9813
  • [9] The molecular basis of disease variability among cystic fibrosis patients carrying the 3849+10 kb C→T mutation
    Chiba-Falek, O
    Kerem, E
    Shoshani, T
    Aviram, M
    Augarten, A
    Bentur, L
    Tal, A
    Tullis, E
    Rahat, A
    Kerem, B
    [J]. GENOMICS, 1998, 53 (03) : 276 - 283
  • [10] Variable levels of normal RNA in different fetal organs carrying a cystic fibrosis transmembrane conductance regulator splicing mutation
    Chiba-Falek, O
    Parad, RB
    Kerem, E
    Kerem, B
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (06) : 1998 - 2002